Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients

Clinical Endocrinology

Volumn 81, Issue 2, 2014, Pages 306-311

  De La Iglesia, Rocio ^a   Lopez Legarrea, Patricia ^a   Crujeiras, Ana B ^b,c,d   Pardo, Maria ^b,c   Casanueva, Felipe F ^b,c   Zulet, Maria A ^a,b   Martinez, Jose A ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

^c Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; IRISIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LOW CALORY DIET; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; BLOOD; FEMALE; MALE; RANDOMIZED CONTROLLED TRIAL;

APOLIPOPROTEINS B; CHOLESTEROL; DIET, REDUCING; FEMALE; FIBRONECTINS; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X;

EID: 84904393468     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12383     Document Type: Article

References (34)

1. Bostrom, P., Wu, J., Jedrychowski, M.P., et al,. (2012) A PGC1-Alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481, 463-468.
2. Spiegelman, B.M., (2013) Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes, 62, 1774-1782.
3. Hojlund, K., &, Bostrom, P., (2013) Irisin in obesity and type 2 diabetes. Journal of Diabetes and its Complications, 27, 303-304.
4. Zhang, H.J., Zhang, X.F., Ma, Z.M., et al,. (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. Journal of Hepatology, 59, 557-562.
5. Kraemer, R.R., Shockett, P., Webb, N.D., et al,. (2013) A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Hormone and Metabolic Research, doi: 10.1055/s-0033-1355381.
6. Vamvini, M.T., Aronis, K.N., Panagiotou, G., et al,. (2013) Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. European Journal of Endocrinology, 169, 829-834.
7. Lansdown, A., Ludgate, M., &, Rees, A., (2012) Metabolic syndrome: is the preadipocyte to blame? Clinical Endocrinology, 76, 19-20.
8. Araujo, A.B., Chiu, G.R., Christian, J.B., et al,. (2013) Longitudinal changes in high-density lipoprotein cholesterol and cardiovascular events in older adults. Clinical endocrinology, doi: 10.1111/cen.12212.
9. Lewington, S., Whitlock, G., Clarke, R., et al,. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-Analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 370, 1829-1839.
10. Baxheinrich, A., Stratmann, B., Lee-Barkey, Y.H., et al,. (2012) Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of alpha-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. British Journal of Nutrition, 108, 682-691.
11. Abete, I., Astrup, A., Martinez, J.A., et al,. (2010) Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutrition reviews, 68, 214-231.
12. Shearer, G.C., Pottala, J.V., Hansen, S.N., et al,. (2012) Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial. Journal of lipid research, 53, 2429-2435.
13. Lopez-Legarrea, P., de la Iglesia, R., Abete, I., et al,. (2013) Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutrition & Metabolism, 10, 22.
14. Zulet, M.A., Bondia-Pons, I., Abete, I., et al,. (2011) The reduction of the metabolic syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutricion Hospitalaria, 26, 16-26.
15. de la Iglesia, R., Lopez-Legarrea, P., Abete, I., et al,. (2013) A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. British Journal of Nutrition, 23, 1-10.
16. Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al,. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752.
17. Food and Nutrition Board, National Research Council (1989) Recommended Dietary Allowances, 10th Edn. The National Academy Press, Washington, DC.
18. Moher, D., Hopewell, S., Schulz, K.F., et al,. (2012) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International Journal of Surgery, 10, 28-55.
19. de la Iglesia, R., Lopez-Legarrea, P., Celada, P., et al,. (2013) Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption. International Journal of Molecular Sciences, 14, 6903-6919.
20. Friedewald, W.T., Levy, R.I., &, Fredrickson, D.S., (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
21. Konig, D., Deibert, P., Frey, I., et al,. (2008) Effect of meal replacement on metabolic risk factors in overweight and obese subjects. Annals of Nutrition and Metabolism, 52, 74-78.
22. Katcher, H.I., Legro, R.S., Kunselman, A.R., et al,. (2008) The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. The American Journal of Clinical Nutrition, 87, 79-90.
23. Polyzos, S.A., Kountouras, J., Shields, K., et al,. (2013) Irisin: a renaissance in metabolism? Metabolism: Clinical and Experimental, 62, 1037-1044.
24. Swick, A.G., Orena, S., &, O'Connor, A., (2013) Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism, 62, 1070-1073.
25. Fernandez, J.M., Rosado-Alvarez, D., Da Silva Grigoletto, M.E., et al,. (2012) Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome. Clinical Science, 123, 361-373.
26. Stengel, A., Hofmann, T., Goebel-Stengel, M., et al,. (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides, 39, 125-130.
27. Park, K.H., Zaichenko, L., Brinkoetter, M., et al,. (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism, 98, 4899-4907.
28. Wrann, C.D., White, J.P., Salogiannnis, J., et al,. (2013) Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 Pathway. Cell metabolism, 18, 649-659.
29. Liu, J.J., Wong, M.D., Toy, W.C., et al,. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of Diabetes and its Complications, 4, 365-369.
30. Choi, Y.K., Kim, M.K., Bae, K.H., et al,. (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice, 100, 96-101.
31. Huh, J.Y., Panagiotou, G., Mougios, V., et al,. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 61, 1725-1738.
32. Wen, M.S., Wang, C.Y., Lin, S.L., et al,. (2013) Decrease in irisin in patients with chronic kidney disease. PLoS One, 8, e64025.
33. Cordero, P., Campion, J., Milagro, F.I., et al,. (2011) Leptin and TNF-Alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. Journal of Physiology and Biochemistry, 67, 463-470.
34. Moreno-Navarrete, J.M., Ortega, F., Serrano, M., et al,. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology & Metabolism, 98, E769-E778.